Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT.
Fiche publication
Date publication
octobre 2017
Journal
Oncotarget
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CASASNOVAS Olivier, Dr MOUNIER Morgane, Dr ROSSI Cédric
Tous les auteurs :
Rossi C, Mounier M, Brice P, Safar V, Nicolas-Virelizier E, Rey P, Stamatoullas-Bastard A, Alcantara M, Chauchet A, Reboursière E, Filliatre L, Perrot A, Garciaz S, Salles G, Coiffier B, Ghesquières H, Casasnovas RO
Lien Pubmed
Résumé
Infradiaphragmatic Hodgkin Lymphoma (IDHL) accounts for 3-11% of adult cases of stage I-II Hodgkin Lymphoma and the treatment strategy in IDHL is still heterogeneous. All previous published studies were conducted before the PET-CT era. PET may provide a more accurate evaluation of IDHL stage. The aim of this study was to analyze the clinical and biological characteristics of IDHL patients staged by CT scan or PET-CT in eight French hematology departments and their impact on outcomes in these patients.
Mots clés
Hodgkin lymphoma, infradiaphragmatic, radiotherapy
Référence
Oncotarget. 2017 Oct 17;8(49):85110-85119